| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.15B | +5.2% |
| Cost of Revenue | $665.8M | +3.6% |
| Gross Profit | $485.7M | +7.4% |
| R&D Expense | $3.5M | +6.1% |
| SG&A Expense | $180.0M | +2.2% |
| Operating Income | $305.7M | +10.7% |
| Pre-tax Income | $305.7M | +10.7% |
| Income Tax | $79.3M | +12.0% |
| Net Income | $226.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -34.0% |
| Accounts Receivable | $88.4M | +114.8% |
| Inventory | $207.3M | +93.6% |
| Current Assets | $318.9M | +85.1% |
| Total Assets | $1.32B | +42.0% |
| Current Liabilities | $342.5M | +276.1% |
| Total Liabilities | $474.2M | +119.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $143.9M | -63.0% |
| Capital Expenditures | $232.3M | +39.9% |
| Investing Cash Flow | -$236.5M | -42.4% |
| Financing Cash Flow | $91.9M | +139.3% |
| Free Cash Flow | -$88.4M | -139.6% |
| +10.2% |
| EPS (Basic) | $2.09 | +10.6% |
| EPS (Diluted) | $2.09 | +10.6% |
| Stockholders' Equity |
| $850.1M |
| +18.6% |